Hematopoietic Stem Cells (HSCs) are a type of multipotent stem cell found in the bone marrow and other tissues responsible for generating all blood cell types. These cells have the unique ability to undergo self-renewal, continuously producing identical stem cells, and differentiate into various blood cells, including red blood cells, white blood cells, and platelets. The process of hematopoiesis, governed by HSCs, is essential for maintaining the body's blood cell supply throughout life. HSCs give rise to progenitor cells, which, in turn, differentiate into specialized blood cells. The balance between self-renewal and differentiation ensures a constant supply of functional blood cells. HSCs are crucial for medical applications, such as bone marrow transplantation, a common treatment for hematological disorders, leukemia, and certain cancers. These cells are also instrumental in understanding blood-related diseases and developing novel therapeutic strategies. Research on hematopoietic stem cells has led to insights into their regulation, mechanisms of differentiation, and their role in immune responses. Advances in stem cell biology have expanded our understanding of HSCs and their potential for regenerative medicine, offering hope for treating various blood disorders and improving transplantation outcomes. Despite progress, challenges remain in fully harnessing the therapeutic potential of HSCs for a broader range of diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States